NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Total Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
---|---|---|---|---|---|
Total Current Assets | ₹690 Cr | ₹572 Cr | ₹520 Cr | ₹468 Cr | ₹120 Cr |
What is the latest Total Current Assets ratio of NATH BIOGENES (INDIA) ?
Year | Total Current Assets |
---|---|
Mar2025 | ₹690 Cr |
Mar2024 | ₹572 Cr |
Mar2023 | ₹520 Cr |
Mar2022 | ₹468 Cr |
Mar2013 | ₹120 Cr |
How is Total Current Assets of NATH BIOGENES (INDIA) Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹690 Cr | 20.70 | |
Mar2024 | ₹572 Cr | 9.97 | |
Mar2023 | ₹520 Cr | 11.13 | |
Mar2022 | ₹468 Cr | 290.62 | |
Mar2013 | ₹120 Cr | - |
Compare Total Current Assets of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹324.4 Cr | -4.1% | -6.3% | -25.9% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,243.9 Cr | -3.8% | -9.9% | -28.9% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,978.5 Cr | -0.2% | 4.5% | 10.1% | Stock Analytics | |
VENKYS (INDIA) | ₹2,060.8 Cr | -2.7% | -3.5% | -36.2% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,513.7 Cr | 4% | 3.2% | -26.9% | Stock Analytics | |
INDO US BIOTECH | ₹298.6 Cr | -1.4% | -7.7% | -45.6% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -4.1% |
-6.3% |
-25.9% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses